Ascentage Pharma Stock Forecast - Simple Exponential Smoothing

AAPG Stock   27.05  0.25  0.92%   
The Simple Exponential Smoothing forecasted value of Ascentage Pharma Group on the next trading day is expected to be 27.31 with a mean absolute deviation of 0.77 and the sum of the absolute errors of 46.33. Ascentage Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Ascentage Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 16th of January 2026 the rsi of Ascentage Pharma's share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Ascentage Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Ascentage Pharma and does not consider all of the tangible or intangible factors available from Ascentage Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Ascentage Pharma Group, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Ascentage Pharma's stock price prediction:
EPS Estimate Current Year
(1.38)
EPS Estimate Next Year
(0.48)
Wall Street Target Price
45.7143
Quarterly Revenue Growth
(0.72)
Using Ascentage Pharma hype-based prediction, you can estimate the value of Ascentage Pharma Group from the perspective of Ascentage Pharma response to recently generated media hype and the effects of current headlines on its competitors.

Ascentage Pharma Hype to Price Pattern

Investor biases related to Ascentage Pharma's public news can be used to forecast risks associated with an investment in Ascentage. The trend in average sentiment can be used to explain how an investor holding Ascentage can time the market purely based on public headlines and social activities around Ascentage Pharma Group. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Ascentage Pharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Ascentage Pharma.
The Simple Exponential Smoothing forecasted value of Ascentage Pharma Group on the next trading day is expected to be 27.31 with a mean absolute deviation of 0.77 and the sum of the absolute errors of 46.33.

Ascentage Pharma after-hype prediction price

    
  USD 27.09  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Ascentage Pharma to cross-verify your projections.
The Ascentage Pharma's current Inventory Turnover is estimated to increase to 4.17. The Ascentage Pharma's current Payables Turnover is estimated to increase to 0.46. The Ascentage Pharma's current Common Stock Shares Outstanding is estimated to increase to about 364.7 M.

Ascentage Pharma Additional Predictive Modules

Most predictive techniques to examine Ascentage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ascentage using various technical indicators. When you analyze Ascentage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Ascentage Pharma simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for Ascentage Pharma Group are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as Ascentage Pharma prices get older.

Ascentage Pharma Simple Exponential Smoothing Price Forecast For the 17th of January 2026

Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Ascentage Pharma Group on the next trading day is expected to be 27.31 with a mean absolute deviation of 0.77, mean absolute percentage error of 0.96, and the sum of the absolute errors of 46.33.
Please note that although there have been many attempts to predict Ascentage Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ascentage Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Ascentage Pharma Stock Forecast Pattern

Backtest Ascentage PharmaAscentage Pharma Price PredictionBuy or Sell Advice 

Ascentage Pharma Forecasted Value

In the context of forecasting Ascentage Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Ascentage Pharma's downside and upside margins for the forecasting period are 23.86 and 30.75, respectively. We have considered Ascentage Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
27.05
27.31
Expected Value
30.75
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Ascentage Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Ascentage Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria116.2363
BiasArithmetic mean of the errors 0.2031
MADMean absolute deviation0.7721
MAPEMean absolute percentage error0.0256
SAESum of the absolute errors46.3267
This simple exponential smoothing model begins by setting Ascentage Pharma Group forecast for the second period equal to the observation of the first period. In other words, recent Ascentage Pharma observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Ascentage Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ascentage Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
23.6427.0930.54
Details
Intrinsic
Valuation
LowRealHigh
24.3534.9938.44
Details
2 Analysts
Consensus
LowTargetHigh
41.6045.7150.74
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.63-0.35-0.1
Details

Other Forecasting Options for Ascentage Pharma

For every potential investor in Ascentage, whether a beginner or expert, Ascentage Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ascentage Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ascentage. Basic forecasting techniques help filter out the noise by identifying Ascentage Pharma's price trends.

Ascentage Pharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ascentage Pharma stock to make a market-neutral strategy. Peer analysis of Ascentage Pharma could also be used in its relative valuation, which is a method of valuing Ascentage Pharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Ascentage Pharma Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ascentage Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ascentage Pharma's current price.

Ascentage Pharma Market Strength Events

Market strength indicators help investors to evaluate how Ascentage Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ascentage Pharma shares will generate the highest return on investment. By undertsting and applying Ascentage Pharma stock market strength indicators, traders can identify Ascentage Pharma Group entry and exit signals to maximize returns.

Ascentage Pharma Risk Indicators

The analysis of Ascentage Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ascentage Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ascentage stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Ascentage Pharma is a strong investment it is important to analyze Ascentage Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascentage Pharma's future performance. For an informed investment choice regarding Ascentage Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Ascentage Pharma to cross-verify your projections.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ascentage Pharma. If investors know Ascentage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ascentage Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.08)
Revenue Per Share
4.78
Quarterly Revenue Growth
(0.72)
Return On Assets
(0.23)
Return On Equity
(1.60)
The market value of Ascentage Pharma is measured differently than its book value, which is the value of Ascentage that is recorded on the company's balance sheet. Investors also form their own opinion of Ascentage Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ascentage Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ascentage Pharma's market value can be influenced by many factors that don't directly affect Ascentage Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ascentage Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascentage Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascentage Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.